Corrigendum to “SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy”
Joint Authors
Okuno, Scott H.
Dickson, Mark A.
Pollock, Raphael E.
George, Suzanne
Chugh, Rashmi
Choy, Edwin
Ballman, Karla
Chen, James
Patel, Rajiv M.
Hoering, Antje
Patel, Shreyaskumar
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-1, 1 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-08-27
Country of Publication
Egypt
No. of Pages
1
Main Subjects
Abstract EN
In the article titled “SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy” [1], the second author, Dr.
Ballman, was paid by Lilly and only recently realized that gemcitabine is a Lilly product and apologizes for not declaring this sooner.
American Psychological Association (APA)
Choy, Edwin& Ballman, Karla& Chen, James& Dickson, Mark A.& Chugh, Rashmi& George, Suzanne…[et al.]. 2019. Corrigendum to “SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy”. Complexity،Vol. 2019, no. 2019, pp.1-1.
https://search.emarefa.net/detail/BIM-1207729
Modern Language Association (MLA)
Choy, Edwin…[et al.]. Corrigendum to “SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy”. Complexity No. 2019 (2019), pp.1-1.
https://search.emarefa.net/detail/BIM-1207729
American Medical Association (AMA)
Choy, Edwin& Ballman, Karla& Chen, James& Dickson, Mark A.& Chugh, Rashmi& George, Suzanne…[et al.]. Corrigendum to “SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy”. Complexity. 2019. Vol. 2019, no. 2019, pp.1-1.
https://search.emarefa.net/detail/BIM-1207729
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1207729
